Lisinopril and Tepezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Tepezza (teprotumumab-trbw). Common drug interactions include fatigue among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Tepezza. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Tepezza?

Tepezza has active ingredients of teprotumumab-trbw. eHealthMe is studying from 3,632 Tepezza users. Check the latest studies of Tepezza.



On Jul, 06, 2026

58 people who take Lisinopril and Tepezza together, and have interactions are studied.

Lisinopril and Tepezza drug interactions.

What are the common drug interactions of Lisinopril and Tepezza, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Muscle spasms (muscle contraction)
  3. Headache (pain in head)
  4. Blood glucose increased
  5. Dizziness
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Hypoacusis (loss of hearing)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Weight decreased
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Fatigue (feeling of tiredness)
  2. Deafness
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Diarrhoea
  5. Disability
  6. Drug ineffective
  7. Dry skin
  8. Dysgeusia (disorder of the sense of taste)
  9. Encephalopathy (functioning of the brain is affected by some agent or condition)
  10. Eye pain

What are the common drug interactions of Lisinopril and Tepezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood glucose increased
  2. Dizziness
  3. Anal fissure
  4. Back pain
  5. Dry skin
  6. Dysgeusia (disorder of the sense of taste)
  7. Fatigue (feeling of tiredness)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Irritable bowel syndrome
  10. Muscle atrophy (a decrease in the mass of the muscle)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Muscle spasms (muscle contraction)
  3. Deafness
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Headache (pain in head)
  6. Tinnitus (a ringing in the ears)
  7. Alopecia (absence of hair from areas of the body)
  8. Blood pressure decreased
  9. Decreased appetite
  10. Diarrhoea

60+:

  1. Fatigue (feeling of tiredness)
  2. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  3. Decreased appetite
  4. Dementia (madness)
  5. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diarrhoea
  8. Diplopia (double vision)
  9. Drug ineffective
  10. Dry eye (lack of adequate tears)

What are the existing conditions these people have? *

  1. Endocrine Ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism): 40 people, 68.97%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Tepezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Tepezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tepezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tepezza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and teprotumumab-trbw (the active ingredients of Lisinopril and Tepezza, respectively), and Lisinopril and Tepezza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: